Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2139757rdf:typepubmed:Citationlld:pubmed
pubmed-article:2139757lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:2139757lifeskim:mentionsumls-concept:C0002395lld:lifeskim
pubmed-article:2139757lifeskim:mentionsumls-concept:C0013080lld:lifeskim
pubmed-article:2139757lifeskim:mentionsumls-concept:C0014792lld:lifeskim
pubmed-article:2139757lifeskim:mentionsumls-concept:C0007367lld:lifeskim
pubmed-article:2139757lifeskim:mentionsumls-concept:C0017822lld:lifeskim
pubmed-article:2139757lifeskim:mentionsumls-concept:C0038838lld:lifeskim
pubmed-article:2139757lifeskim:mentionsumls-concept:C1280464lld:lifeskim
pubmed-article:2139757pubmed:issue4lld:pubmed
pubmed-article:2139757pubmed:dateCreated1990-6-7lld:pubmed
pubmed-article:2139757pubmed:abstractTextThe activities of red blood cell enzymes that scavenge the superoxide radical and hydrogen peroxide were measured in severely to profoundly retarded adult Down syndrome (DS) patients with and without manifestations of Alzheimer disease (AD), and control individuals matched for sex, age, and time of blood sampling. Cu,Zn superoxide dismutase (SOD-1) and glutathione peroxidase (GSHPx) activities were significantly elevated (1.39-fold and 1.24-fold, respectively) in DS individuals without AD. When an adjustment was made for the SOD gene dosage effect, DS patients with AD manifestations had significantly lower SOD levels than the matched control individuals. In contrast, DS patients with and without AD had a similar elevation in GSHPx (an adaptive phenomenon). The mean catalase (CAT) activity was no different in DS and control individuals; however, in a paired regression analysis, DS patients without AD had marginally lower CAT activity than control individuals, whereas DS patients with AD had slightly but not significantly higher CAT activity. Thus, AD manifestations in this DS population are associated with changes in the red cell oxygen scavenging processes.lld:pubmed
pubmed-article:2139757pubmed:languageenglld:pubmed
pubmed-article:2139757pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2139757pubmed:citationSubsetIMlld:pubmed
pubmed-article:2139757pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2139757pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2139757pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2139757pubmed:statusMEDLINElld:pubmed
pubmed-article:2139757pubmed:monthAprlld:pubmed
pubmed-article:2139757pubmed:issn0148-7299lld:pubmed
pubmed-article:2139757pubmed:authorpubmed-author:DaltonA JAJlld:pubmed
pubmed-article:2139757pubmed:authorpubmed-author:PercyM EMElld:pubmed
pubmed-article:2139757pubmed:authorpubmed-author:RushA FAFlld:pubmed
pubmed-article:2139757pubmed:authorpubmed-author:MarkovicV DVDlld:pubmed
pubmed-article:2139757pubmed:authorpubmed-author:McLachlanD...lld:pubmed
pubmed-article:2139757pubmed:authorpubmed-author:AndrewsD FDFlld:pubmed
pubmed-article:2139757pubmed:authorpubmed-author:HummelJ TJTlld:pubmed
pubmed-article:2139757pubmed:issnTypePrintlld:pubmed
pubmed-article:2139757pubmed:volume35lld:pubmed
pubmed-article:2139757pubmed:ownerNLMlld:pubmed
pubmed-article:2139757pubmed:authorsCompleteYlld:pubmed
pubmed-article:2139757pubmed:pagination459-67lld:pubmed
pubmed-article:2139757pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:2139757pubmed:meshHeadingpubmed-meshheading:2139757-...lld:pubmed
pubmed-article:2139757pubmed:meshHeadingpubmed-meshheading:2139757-...lld:pubmed
pubmed-article:2139757pubmed:meshHeadingpubmed-meshheading:2139757-...lld:pubmed
pubmed-article:2139757pubmed:meshHeadingpubmed-meshheading:2139757-...lld:pubmed
pubmed-article:2139757pubmed:meshHeadingpubmed-meshheading:2139757-...lld:pubmed
pubmed-article:2139757pubmed:meshHeadingpubmed-meshheading:2139757-...lld:pubmed
pubmed-article:2139757pubmed:meshHeadingpubmed-meshheading:2139757-...lld:pubmed
pubmed-article:2139757pubmed:meshHeadingpubmed-meshheading:2139757-...lld:pubmed
pubmed-article:2139757pubmed:meshHeadingpubmed-meshheading:2139757-...lld:pubmed
pubmed-article:2139757pubmed:meshHeadingpubmed-meshheading:2139757-...lld:pubmed
pubmed-article:2139757pubmed:meshHeadingpubmed-meshheading:2139757-...lld:pubmed
pubmed-article:2139757pubmed:meshHeadingpubmed-meshheading:2139757-...lld:pubmed
pubmed-article:2139757pubmed:meshHeadingpubmed-meshheading:2139757-...lld:pubmed
pubmed-article:2139757pubmed:meshHeadingpubmed-meshheading:2139757-...lld:pubmed
pubmed-article:2139757pubmed:meshHeadingpubmed-meshheading:2139757-...lld:pubmed
pubmed-article:2139757pubmed:meshHeadingpubmed-meshheading:2139757-...lld:pubmed
pubmed-article:2139757pubmed:year1990lld:pubmed
pubmed-article:2139757pubmed:articleTitleRed cell superoxide dismutase, glutathione peroxidase and catalase in Down syndrome patients with and without manifestations of Alzheimer disease.lld:pubmed
pubmed-article:2139757pubmed:affiliationDepartment of Obstetrics and Gynaecology, University of Toronto, Mount Sinai Hospital, Canada.lld:pubmed
pubmed-article:2139757pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2139757pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2139757lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2139757lld:pubmed